MCK Stock Cash Flow Statements

McKesson Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

McKesson Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31

operating activities
net income	831,000,000	1,306,000,000	928,000,000	287,000,000	960,000,000	830,000,000	630,000,000	703,000,000	997,000,000	826,000,000	1,120,000,000	967,000,000	809,000,000	405,000,000	39,000,000	310,000,000	533,000,000	713,000,000	-6,174,000,000	627,000,000	494,000,000	1,078,000,000	242,000,000	-677,000,000	477,000,000	-744,000,000	526,000,000	553,000,000	-80,000,000	-1,085,000,000	961,000,000	56,000,000	365,000,000	3,623,000,000	646,000,000	324,000,000	560,000,000	444,000,000	647,000,000	630,000,000	589,000,000	144,000,000	511,000,000	477,000,000	411,000,000	366,000,000	64,000,000	404,000,000	424,000,000	259,000,000	298,000,000	401,000,000	380,000,000	521,000,000	300,000,000	296,000,000	286,000,000	422,000,000	155,000,000	327,000,000	298,000,000	348,000,000	326,000,000	301,000,000	288,000,000	281,000,000	-20,000,000	327,000,000	235,000,000	307,000,000	201,000,000	247,000,000	235,000,000	257,000,000	243,000,000	229,000,000	184,000,000	220,000,000					-665,400,000	86,100,000	163,600,000								117,300,000
adjustments to reconcile to net cash from operating activities:
depreciation	62,000,000	60,000,000	58,000,000	61,000,000	63,000,000	62,000,000	62,000,000	65,000,000	64,000,000	63,000,000	61,000,000	63,000,000	61,000,000	64,000,000	67,000,000	68,000,000	80,000,000	84,000,000	83,000,000	79,000,000	75,000,000																																																													28,400,000	27,600,000	28,100,000	27,400,000	31,000,000	24,300,000	24,400,000	25,100,000	25,000,000	24,000,000	24,700,000	27,500,000
amortization	95,000,000	91,000,000	95,000,000	102,000,000	106,000,000	98,000,000	97,000,000	92,000,000	95,000,000	98,000,000	87,000,000	88,000,000	87,000,000	98,000,000	118,000,000	127,000,000	138,000,000	137,000,000	144,000,000	143,000,000	142,000,000																																																													36,700,000	34,700,000	34,100,000	33,900,000	35,800,000	33,100,000	30,500,000	27,900,000	27,900,000	26,000,000	25,400,000	23,200,000
asset impairment charges	2,000,000		7,000,000
deferred taxes	-8,000,000	-260,000,000	25,000,000	97,000,000	28,000,000	-51,000,000	-281,000,000	-36,000,000	-235,000,000	-75,000,000	-115,000,000	61,000,000	109,000,000	22,000,000	30,000,000	-54,000,000	36,000,000	612,000,000	-1,485,000,000	-63,000,000	28,000,000	45,000,000	-7,000,000	-396,000,000	16,000,000	19,000,000	110,000,000	15,000,000	45,000,000	-21,000,000	-889,000,000	-43,000,000	85,000,000	760,000,000	212,000,000	-121,000,000	31,000,000	34,000,000	7,000,000	0	23,000,000	116,000,000	-55,000,000	-25,000,000	135,000,000		-66,000,000																	44,000,000	60,000,000			52,000,000	10,000,000	6,000,000	151,000,000	145,000,000	-104,000,000	90,000,000	7,000,000	12,000,000	58,000,000	160,000,000	132,000,000	78,000,000	33,000,000
charges associated with last-in, first-out inventory method	-7,000,000
non-cash operating lease expense	70,000,000	66,000,000	66,000,000	56,000,000	57,000,000	42,000,000	64,000,000	64,000,000	58,000,000	66,000,000	57,000,000	63,000,000	63,000,000	43,000,000	46,000,000	62,000,000	90,000,000	70,000,000	92,000,000	89,000,000	83,000,000	90,000,000	96,000,000
gain from sales of businesses and investments	17,000,000	-86,000,000	660,000,000	-3,000,000	-86,000,000	0	-1,000,000	3,000,000	-19,000,000	4,000,000	-67,000,000	-115,000,000	-33,000,000	-15,000,000	-16,000,000
benefit from bad debts	196,000,000	14,000,000	25,000,000	-184,000,000	15,000,000	39,000,000																																																																								-6,000,000				-1,900,000	4,700,000	6,100,000	6,700,000	100,000	14,500,000	37,200,000	2,600,000	11,200,000	10,300,000	27,000,000	20,000,000
other non-cash items	57,000,000	213,000,000	37,000,000	105,000,000	69,000,000	96,000,000	-177,000,000	273,000,000	41,000,000	77,000,000	64,000,000	55,000,000	102,000,000	49,000,000	71,000,000	187,000,000	194,000,000	121,000,000	50,000,000	8,000,000	9,000,000	73,000,000	398,000,000	23,000,000	121,000,000	68,000,000	122,000,000	-59,000,000	-79,000,000	130,000,000	-104,000,000	-36,000,000	8,000,000	38,000,000	45,000,000	-24,000,000	29,000,000	-31,000,000	132,000,000	38,000,000	-31,000,000	100,000,000	-71,000,000	4,000,000	14,000,000	47,000,000	21,000,000	30,000,000	32,000,000	3,000,000	33,000,000			-36,000,000	50,000,000	13,000,000	39,000,000	-46,000,000	-23,000,000	69,000,000	12,000,000	-13,000,000	-3,000,000	-22,000,000	18,000,000	-5,000,000	2,000,000	0	-1,000,000	-29,000,000	-14,000,000	37,000,000	-18,000,000	-47,000,000	-14,000,000	-27,000,000	12,000,000	6,000,000	0	3,000,000	-1,000,000	5,200,000	-3,600,000	-1,400,000	-1,000,000	34,600,000	400,000	-18,500,000	-1,900,000	-800,000	10,300,000	-6,100,000	5,700,000
changes in assets and liabilities:
receivables	-2,089,000,000	129,000,000	-565,000,000	-1,398,000,000	-2,101,000,000	1,344,000,000	-1,091,000,000	-827,000,000	-2,380,000,000	1,111,000,000	-310,000,000	-299,000,000	-1,584,000,000	82,000,000	386,000,000	-1,266,000,000	-1,045,000,000	-355,000,000	519,000,000	-1,310,000,000	2,291,000,000	-1,450,000,000	-178,000,000	195,000,000	-1,061,000,000	576,000,000	162,000,000	-291,000,000	-1,414,000,000	2,221,000,000	-234,000,000	-449,000,000	-363,000,000	-108,000,000	3,000,000	-357,000,000	-300,000,000	-290,000,000	-630,000,000	-288,000,000	-749,000,000	11,000,000	-1,297,000,000	-836,000,000	-699,000,000	-20,000,000	-475,000,000	-245,000,000	-145,000,000	269,000,000	-162,000,000	-225,000,000	444,000,000	-195,000,000	-140,000,000	-240,000,000	-195,000,000	-475,000,000	-53,000,000	-317,000,000	172,000,000	282,000,000	-466,000,000	-250,000,000	301,000,000	173,000,000	-544,000,000	-26,000,000	-311,000,000	142,000,000	-268,000,000	27,000,000	-189,000,000	-77,000,000	-388,000,000	121,000,000	135,000,000	-85,000,000	-502,000,000	85,000,000	-23,000,000	-104,300,000	-62,200,000	-92,500,000	-65,900,000	-5,600,000	-322,200,000	87,600,000	-464,500,000	-796,700,000	593,100,000	-245,100,000	-192,900,000
inventories	-1,971,000,000	864,000,000	176,000,000	1,132,000,000	-4,442,000,000	1,090,000,000	-35,000,000	-1,523,000,000	-826,000,000	931,000,000	-737,000,000	-498,000,000	-955,000,000	490,000,000	-495,000,000	-263,000,000	-901,000,000	-230,000,000	-650,000,000	-1,634,000,000	238,000,000	313,000,000	-1,020,000,000	186,000,000	145,000,000	388,000,000	-358,000,000	-284,000,000	-114,000,000	952,000,000	-193,000,000	-1,158,000,000	-59,000,000	694,000,000	-536,000,000	283,000,000	-121,000,000	1,146,000,000	-928,000,000	-834,000,000	-635,000,000	510,000,000	-1,493,000,000	-260,000,000	-901,000,000	186,000,000	-1,152,000,000	-175,000,000	-60,000,000	254,000,000	-329,000,000			322,000,000	-931,000,000	34,000,000	-303,000,000	345,000,000	-640,000,000	690,000,000	-28,000,000	-577,000,000	-229,000,000	66,000,000	-42,000,000	860,000,000	-321,000,000	103,000,000	-272,000,000	555,000,000	-1,166,000,000	-261,000,000	196,000,000	536,000,000	-829,000,000	-189,000,000	-446,000,000	944,000,000	-619,000,000	-9,000,000	262,000,000	814,600,000	-362,700,000	-535,500,000	-636,400,000	365,900,000	-147,200,000	-976,300,000	76,300,000	536,300,000	-547,200,000	179,700,000	-155,400,000
drafts and accounts payable	1,947,000,000	5,624,000,000	-3,544,000,000	1,605,000,000	4,616,000,000	424,000,000	-144,000,000	2,834,000,000	1,473,000,000	257,000,000	1,239,000,000	1,286,000,000	1,006,000,000	1,190,000,000	181,000,000	2,040,000,000	-609,000,000	2,507,000,000	65,000,000	2,909,000,000	-4,214,000,000	4,881,000,000	274,000,000	-1,330,000,000	127,000,000	1,801,000,000	-1,022,000,000	1,165,000,000	32,000,000	-932,000,000	-605,000,000	1,345,000,000	463,000,000	179,000,000	-281,000,000	623,000,000	1,549,000,000	1,607,000,000	-265,000,000	957,000,000	1,003,000,000	554,000,000	2,662,000,000	134,000,000	1,368,000,000	1,828,000,000	237,000,000	-245,000,000	592,000,000	956,000,000	-452,000,000	307,000,000	-936,000,000	391,000,000	756,000,000	435,000,000	445,000,000	481,000,000	469,000,000	-497,000,000	80,000,000	209,000,000	320,000,000	455,000,000	356,000,000	-573,000,000	367,000,000	-312,000,000	329,000,000	-299,000,000	270,000,000	689,000,000	102,000,000	-42,000,000	460,000,000	149,000,000	305,000,000	-122,000,000	124,000,000	1,060,000,000	48,000,000	-84,000,000	53,200,000	678,900,000	664,100,000	277,900,000	67,600,000	237,400,000	317,200,000
operating lease liabilities	-89,000,000	-99,000,000	-109,000,000	-100,000,000	-96,000,000	-92,000,000	-81,000,000	-86,000,000	-80,000,000	-82,000,000	-82,000,000	-80,000,000	-94,000,000	-80,000,000	-90,000,000	-96,000,000	-90,000,000	-71,000,000	-106,000,000	-96,000,000	-89,000,000	-90,000,000	-98,000,000
taxes	134,000,000	152,000,000	-143,000,000	66,000,000	-211,000,000	371,000,000	36,000,000	-312,000,000	236,000,000	-18,000,000	299,000,000	45,000,000	37,000,000	67,000,000	136,000,000	94,000,000	-54,000,000	-350,000,000	242,000,000	-134,000,000	76,000,000	-19,000,000	-59,000,000	-12,000,000	82,000,000	36,000,000	-32,000,000	-38,000,000	-61,000,000	-18,000,000	603,000,000	104,000,000	-18,000,000	94,000,000	-99,000,000	56,000,000	95,000,000	-192,000,000	-89,000,000	-2,000,000	205,000,000	-19,000,000	-137,000,000	68,000,000	-134,000,000	64,000,000	148,000,000	-27,000,000	33,000,000	8,000,000	29,000,000	25,000,000	-142,000,000									-7,000,000	35,000,000	43,000,000	17,000,000	-154,000,000	59,000,000	-14,000,000	62,000,000	112,000,000	32,000,000	-46,000,000	238,000,000	109,000,000	2,000,000	-7,000,000	40,000,000	-55,000,000	-27,000,000	-6,000,000	35,000,000	56,100,000	110,500,000	-4,200,000	-49,200,000	63,200,000	36,600,000	-42,900,000	4,700,000
litigation liabilities		-15,000,000	0	-500,000,000	114,000,000	134,000,000	0			-67,000,000	-106,000,000	-545,000,000	-370,000,000	53,000,000	-5,000,000	77,000,000	74,000,000	0
other	-165,000,000	-323,000,000	450,000,000	65,000,000	-473,000,000	-9,000,000	393,000,000	189,000,000	-536,000,000	43,000,000	116,000,000	83,000,000	-186,000,000	78,000,000	140,000,000	137,000,000	-149,000,000	108,000,000	196,000,000	357,000,000	-150,000,000	-25,000,000	-60,000,000	250,000,000	-173,000,000	229,000,000	66,000,000	43,000,000	-270,000,000	8,000,000	227,000,000	26,000,000	-39,000,000	-91,000,000	116,000,000	-117,000,000	-273,000,000	181,000,000	-38,000,000	139,000,000	-145,000,000	-123,000,000	322,000,000	103,000,000	-260,000,000	-61,000,000	312,000,000	120,000,000	-285,000,000	-10,000,000	242,000,000	3,000,000	-284,000,000	-62,000,000	183,000,000	38,000,000	-70,000,000	-48,000,000	38,000,000	-44,000,000	-90,000,000	119,000,000	87,000,000	-43,000,000	-142,000,000	66,000,000	95,000,000	-37,000,000	-141,000,000	-27,000,000	146,000,000	-34,000,000	-80,000,000	101,000,000	114,000,000	-6,000,000	-82,000,000	48,000,000	15,000,000	-18,000,000	-84,000,000	-7,000,000	54,700,000	78,700,000	-86,800,000	-66,600,000	42,000,000	57,300,000	-102,200,000	-33,400,000	56,600,000	18,400,000	-41,200,000	71,400,000
net cash from operating activities	-918,000,000	7,748,000,000	-2,383,000,000	2,100,000,000	-1,380,000,000	4,147,000,000	254,000,000	965,000,000	-1,052,000,000	3,325,000,000	1,668,000,000	1,107,000,000	-941,000,000	2,887,000,000	1,377,000,000	1,792,000,000	-1,622,000,000	3,370,000,000	1,213,000,000	1,021,000,000	-1,062,000,000	4,654,000,000	-121,000,000	-108,000,000	-51,000,000	3,895,000,000	-177,000,000	1,379,000,000	-1,061,000,000	3,022,000,000	-16,000,000	598,000,000	741,000,000	1,435,000,000	381,000,000	1,069,000,000	1,859,000,000	3,106,000,000	-685,000,000	797,000,000	454,000,000	1,883,000,000	1,064,000,000	-17,000,000	182,000,000	2,664,000,000	-341,000,000	97,000,000	716,000,000	2,207,000,000	-183,000,000	1,011,000,000	-552,000,000	1,234,000,000	321,000,000	1,069,000,000	326,000,000	1,000,000,000	540,000,000	270,000,000	528,000,000	591,000,000	192,000,000	626,000,000	907,000,000	617,000,000	186,000,000	234,000,000	314,000,000	916,000,000	-1,319,000,000	840,000,000	432,000,000	984,000,000	-130,000,000	390,000,000	295,000,000	1,267,000,000	-532,000,000	1,372,000,000	637,000,000				128,300,000
capex	-189,000,000	-278,000,000	-196,000,000	-218,000,000	-167,000,000	-269,000,000	-154,000,000	-140,000,000	-124,000,000	-182,000,000	-154,000,000	-122,000,000	-100,000,000	-155,000,000	-101,000,000	-120,000,000	-159,000,000	-214,000,000	-162,000,000	-46,000,000	-117,000,000	-168,000,000	-154,000,000	-73,000,000	-111,000,000	-152,000,000	-157,000,000	-103,000,000	-145,000,000	-188,000,000	-137,000,000	-137,000,000	-118,000,000	-193,000,000	-129,000,000	-126,000,000	-114,000,000	-44,000,000	-49,000,000	-53,000,000	-43,000,000	-50,000,000	-38,000,000	-48,000,000	-33,000,000	-33,000,000	-42,000,000	-34,000,000	-32,000,000	-43,000,000	-36,000,000	-43,000,000	-38,000,000	-41,000,000	-36,000,000	-50,000,000	-51,000,000	-44,000,000	-36,000,000	-40,000,000	-35,000,000	-45,000,000	-38,000,000	-52,000,000	-44,000,000	-60,000,000	-47,000,000	-52,000,000	-38,000,000	-43,000,000	-40,000,000	-37,000,000	-41,000,000	-61,000,000	-33,000,000	-38,000,000	-48,000,000	-32,000,000	-62,000,000	-34,000,000	-32,000,000				-37,000,000
free cash flows	-1,107,000,000	7,470,000,000	-2,579,000,000	1,882,000,000	-1,547,000,000	3,878,000,000	100,000,000	825,000,000	-1,176,000,000	3,143,000,000	1,514,000,000	985,000,000	-1,041,000,000	2,732,000,000	1,276,000,000	1,672,000,000	-1,781,000,000	3,156,000,000	1,051,000,000	975,000,000	-1,179,000,000	4,486,000,000	-275,000,000	-181,000,000	-162,000,000	3,743,000,000	-334,000,000	1,276,000,000	-1,206,000,000	2,834,000,000	-153,000,000	461,000,000	623,000,000	1,242,000,000	252,000,000	943,000,000	1,745,000,000	3,062,000,000	-734,000,000	744,000,000	411,000,000	1,833,000,000	1,026,000,000	-65,000,000	149,000,000	2,631,000,000	-383,000,000	63,000,000	684,000,000	2,164,000,000	-219,000,000	968,000,000	-590,000,000	1,193,000,000	285,000,000	1,019,000,000	275,000,000	956,000,000	504,000,000	230,000,000	493,000,000	546,000,000	154,000,000	574,000,000	863,000,000	557,000,000	139,000,000	182,000,000	276,000,000	873,000,000	-1,359,000,000	803,000,000	391,000,000	923,000,000	-163,000,000	352,000,000	247,000,000	1,235,000,000	-594,000,000	1,338,000,000	605,000,000				91,300,000
investing activities
payments for property, plant, and equipment	-111,000,000	-169,000,000	-126,000,000	-136,000,000	-106,000,000	-188,000,000	-90,000,000	-75,000,000	-78,000,000	-125,000,000	-108,000,000	-86,000,000	-71,000,000	-135,000,000	-67,000,000	-93,000,000	-93,000,000	-158,000,000	-119,000,000
capitalized software expenditures	-78,000,000	-109,000,000	-70,000,000	-82,000,000	-61,000,000	-81,000,000	-64,000,000	-65,000,000	-46,000,000	-57,000,000	-46,000,000	-36,000,000	-29,000,000	-20,000,000	-34,000,000	-27,000,000	-66,000,000	-56,000,000	-43,000,000	-46,000,000	-45,000,000	-48,000,000	-38,000,000	-34,000,000	-24,000,000	-35,000,000	-26,000,000	-26,000,000	-44,000,000	-52,000,000	-32,000,000	-48,000,000	-43,000,000	-35,000,000	-34,000,000	-51,000,000	-38,000,000	-44,000,000	-49,000,000	-53,000,000	-43,000,000	-50,000,000	-38,000,000	-48,000,000	-33,000,000	-33,000,000	-42,000,000	-34,000,000	-32,000,000	-43,000,000	-36,000,000	-43,000,000	-38,000,000	-41,000,000	-36,000,000	-50,000,000	-51,000,000	-44,000,000	-36,000,000	-40,000,000	-35,000,000	-45,000,000	-38,000,000	-52,000,000	-44,000,000	-60,000,000	-47,000,000	-52,000,000	-38,000,000	-43,000,000	-40,000,000	-37,000,000	-41,000,000	-61,000,000	-33,000,000	-38,000,000	-48,000,000	-32,000,000	-62,000,000	-34,000,000	-32,000,000	-44,500,000	-25,800,000	-30,400,000	-37,000,000	-41,000,000	-35,600,000	-44,600,000	-50,800,000	-51,600,000	-45,500,000	-47,500,000	-39,100,000
acquisitions, net of cash, cash equivalents, and restricted cash acquired	-3,359,000,000	-21,000,000	-2,000,000			-266,000,000				-11,000,000	-833,000,000	-22,000,000	-1,000,000	0	-2,000,000	-3,000,000	-1,000,000	-2,000,000	-25,000,000
proceeds from sales of businesses and investments	4,000,000	96,000,000	-10,000,000	3,000,000	90,000,000	0	-3,000,000	11,000,000	39,000,000	3,000,000	578,000,000	256,000,000	240,000,000	381,000,000	18,000,000	96,000,000	83,000,000	75,000,000	316,000,000	2,000,000	7,000,000
net cash from investing activities	-3,564,000,000	-224,000,000	-136,000,000	-286,000,000	-87,000,000	-577,000,000	-180,000,000	-166,000,000	-149,000,000	-244,000,000	-414,000,000	77,000,000	39,000,000	183,000,000	-115,000,000	-58,000,000	-99,000,000	-205,000,000	68,000,000	-148,000,000	-130,000,000	-170,000,000	-124,000,000	-156,000,000	-129,000,000	-230,000,000	-168,000,000	-108,000,000	-875,000,000	-1,039,000,000	-87,000,000	-267,000,000	-129,000,000	-177,000,000	-2,273,000,000	-192,000,000	-1,154,000,000	-1,329,000,000	-159,000,000	-52,000,000	-17,000,000	-238,000,000	-132,000,000	-195,000,000	-112,000,000	-4,624,000,000	-148,000,000	-90,000,000	-184,000,000	-1,425,000,000	-433,000,000	-201,000,000	-150,000,000	-1,072,000,000	-81,000,000	-195,000,000	-154,000,000	-158,000,000	-371,000,000	-16,000,000	-79,000,000	-106,000,000	-11,000,000	-106,000,000	-86,000,000	-195,000,000	-79,000,000	-91,000,000	-362,000,000	-119,000,000	342,000,000	-138,000,000	-90,000,000	-1,951,000,000	-57,000,000	109,000,000	-204,000,000	-1,043,000,000	-124,000,000	-567,000,000	-91,000,000
financing activities
proceeds from short-term borrowings		3,691,000,000	4,519,000,000	5,515,000,000	1,361,000,000	15,194,000,000	2,770,000,000	1,935,000,000	65,000,000	7,350,000,000	1,000,000,000			7,550,000,000	622,000,000			868,000,000	152,000,000	0	5,303,000,000	5,585,000,000	7,182,000,000	6,060,000,000	2,610,000,000	6,873,000,000	10,657,000,000	10,699,000,000	9,036,000,000	7,843,000,000	4,235,000,000	6,182,000,000	2,282,000,000	5,491,000,000	2,793,000,000	3,000,000	7,000,000	29,000,000	31,000,000	970,000,000	531,000,000	649,000,000	661,000,000	873,000,000	917,000,000	5,995,000,000	0	50,000,000	100,000,000	1,100,000,000	0											0	0			28,000,000	70,000,000
repayments of short-term borrowings		-6,116,000,000	-2,094,000,000	-5,515,000,000	-1,361,000,000	-15,412,000,000	-2,552,000,000	-1,935,000,000	-65,000,000	-7,967,000,000	-383,000,000			-7,922,000,000	-250,000,000			-1,020,000,000	0	0	-5,303,000,000	-7,694,000,000	-5,621,000,000	-5,512,000,000	-2,610,000,000	-7,922,000,000	-11,004,000,000	-11,337,000,000	-7,005,000,000	-8,592,000,000	-3,790,000,000	-5,880,000,000	-2,463,000,000	-6,719,000,000	-1,388,000,000	-3,000,000	-14,000,000	-20,000,000	-167,000,000	-967,000,000	-534,000,000	-825,000,000	-755,000,000	-813,000,000	-759,000,000	-5,972,000,000	0	-50,000,000	-100,000,000	-1,100,000,000	0	-1,125,000,000	-400,000,000									0	0	0	-6,000,000	-28,000,000	-70,000,000	-2,974,000,000	-558,000,000
proceeds from issuances of long-term debt	1,990,000,000	0	0			0	0	0	991,000,000	498,000,000				0	0			0								0																-8,000,000	4,000,000	1,000,000	6,000,000					906,000,000
common stock transactions:
issuances	22,000,000	28,000,000	19,000,000	32,000,000	22,000,000	41,000,000	21,000,000	27,000,000	27,000,000	20,000,000	16,000,000	36,000,000	91,000,000	46,000,000	63,000,000	40,000,000	71,000,000	37,000,000	16,000,000	18,000,000	21,000,000	24,000,000	11,000,000	56,000,000	22,000,000	29,000,000	8,000,000	16,000,000	22,000,000	18,000,000	31,000,000	56,000,000	27,000,000	31,000,000	14,000,000	39,000,000	36,000,000	26,000,000	25,000,000	34,000,000	38,000,000	37,000,000	49,000,000	32,000,000	34,000,000	27,000,000	31,000,000	69,000,000	50,000,000	54,000,000	32,000,000	37,000,000	43,000,000													20,000,000	12,000,000	35,000,000	30,000,000	57,000,000	114,000,000	34,000,000	149,000,000	160,000,000	48,000,000	131,000,000	60,000,000	133,000,000	153,000,000	127,000,000	155,000,000	106,200,000			83,000,000	10,800,000	24,200,000	22,900,000	34,700,000	8,900,000	23,200,000	7,300,000	39,400,000
share repurchases	-581,000,000	-300,000,000	-827,000,000	-1,492,000,000	-527,000,000	-678,000,000	-842,000,000	-809,000,000	-696,000,000	-138,000,000	-2,016,000,000	-484,000,000	-1,000,000,000	-1,530,000,000	-714,000,000	-264,000,000	-1,008,000,000																																																					-772,000,000	-231,000,000	-428,000,000	-267,000,000	-247,000,000	-98,000,000	-375,000,000	-283,000,000	-379,000,000	-289,000,000	-224,000,000	-66,000,000					-41,500,000	-40,000,000	0	-75,300,000	0
dividends paid	-90,000,000	-91,000,000	-92,000,000	-80,000,000	-82,000,000	-82,000,000	-83,000,000	-75,000,000	-74,000,000	-76,000,000	-77,000,000	-68,000,000	-71,000,000	-71,000,000	-72,000,000	-65,000,000	-69,000,000	-67,000,000	-69,000,000	-66,000,000	-74,000,000	-72,000,000	-74,000,000	-73,000,000	-75,000,000	-76,000,000	-77,000,000	-68,000,000	-71,000,000	-70,000,000	-71,000,000	-59,000,000	-62,000,000	-61,000,000	-63,000,000	-63,000,000	-66,000,000	-65,000,000	-65,000,000	-55,000,000	-59,000,000	-56,000,000	-56,000,000	-56,000,000	-59,000,000	-60,000,000	-55,000,000	-46,000,000	-53,000,000	-47,000,000	-47,000,000	-47,000,000	-53,000,000	-49,000,000	-49,000,000	-50,000,000	-47,000,000	-45,000,000	-46,000,000	-47,000,000	-33,000,000	-33,000,000	-32,000,000	-32,000,000	-34,000,000	-33,000,000	-33,000,000	-33,000,000	-17,000,000	-17,000,000	-17,000,000	-18,000,000	-18,000,000	-18,000,000	-18,000,000	-18,000,000	-18,000,000	-18,000,000	-19,000,000	-18,000,000	-18,000,000	-17,900,000	-17,700,000	-17,500,000	-17,500,000	-17,500,000	-17,500,000	-17,300,000	-17,500,000	-17,400,000	-17,700,000	-17,300,000	-17,300,000
net cash from financing activities	1,176,000,000	-2,855,000,000	1,298,000,000	-1,599,000,000	-809,000,000	-968,000,000	-622,000,000	-909,000,000	-843,000,000	-1,190,000,000	-1,425,000,000	-572,000,000	-1,181,000,000	-1,989,000,000	-438,000,000	-1,743,000,000	-2,151,000,000	-517,000,000	-775,000,000	-462,000,000	61,000,000	-2,480,000,000	949,000,000	-331,000,000	-872,000,000	-2,544,000,000	119,000,000	-1,343,000,000	1,541,000,000	-1,937,000,000	125,000,000	-141,000,000	-1,131,000,000	-924,000,000	-1,031,000,000	-32,000,000	-82,000,000	-1,206,000,000	-1,057,000,000	-987,000,000	-203,000,000	-716,000,000	-84,000,000	-1,000,000	-167,000,000	3,692,000,000	-36,000,000	36,000,000	-73,000,000	-1,038,000,000	515,000,000	-8,000,000	-425,000,000	-1,208,000,000	-12,000,000	-17,000,000	-668,000,000	-445,000,000	-20,000,000	-473,000,000	-903,000,000	-184,000,000	30,000,000	36,000,000	-303,000,000	527,000,000	-20,000,000	-199,000,000	-130,000,000	-871,000,000	-101,000,000	-405,000,000	-93,000,000	908,000,000	-54,000,000	-242,000,000	-233,000,000	-265,000,000	-157,000,000	-218,000,000	63,000,000	-162,200,000	9,300,000
effect of exchange rate changes on cash, cash equivalents, and restricted cash	33,000,000	5,000,000	-22,000,000	6,000,000	-5,000,000	0	7,000,000	-3,000,000	2,000,000	10,000,000	-9,000,000	6,000,000	18,000,000	20,000,000	17,000,000	7,000,000	11,000,000	16,000,000	-14,000,000
net decrease in cash, cash equivalents, and restricted cash	-3,273,000,000		-1,229,000,000	207,000,000	-2,281,000,000		-541,000,000	-113,000,000	-2,042,000,000		-180,000,000	618,000,000	-1,595,000,000		626,000,000	-2,000,000	-3,861,000,000		492,000,000
cash, cash equivalents, and restricted cash at beginning of period	5,956,000,000		0	0	4,585,000,000		0	0	4,679,000,000		0	0	3,935,000,000		0	0	6,396,000,000		0
cash, cash equivalents, and restricted cash at end of period	2,683,000,000		-1,229,000,000	207,000,000	2,304,000,000		-541,000,000	-113,000,000	2,637,000,000		-180,000,000	618,000,000	2,340,000,000		626,000,000	-2,000,000	2,535,000,000		492,000,000
less: restricted cash at end of period included in prepaid expenses and other	-265,000,000		-149,000,000	0	-2,000,000				-1,000,000		38,000,000	65,000,000	-107,000,000		-23,000,000	-270,000,000	-112,000,000		-6,000,000	102,000,000	-251,000,000
cash and cash equivalents at end of period	2,418,000,000		-1,378,000,000	207,000,000	2,302,000,000		-542,000,000	-112,000,000	2,636,000,000		-142,000,000	683,000,000	2,233,000,000		603,000,000	-272,000,000	2,423,000,000		486,000,000	478,000,000	2,613,000,000										56,000,000	224,000,000	2,339,000,000		-3,030,000,000	805,000,000	4,659,000,000		-1,953,000,000	-276,000,000	5,635,000,000		783,000,000	-301,000,000	4,105,000,000		-529,000,000	55,000,000	2,905,000,000		-105,000,000	818,000,000	2,013,000,000		248,000,000	827,000,000	3,116,000,000		163,000,000	-215,000,000	3,265,000,000		213,000,000	571,000,000	2,644,000,000		52,000,000	-64,000,000	1,187,000,000		-1,082,000,000	315,000,000	2,203,000,000		-241,000,000	254,000,000	2,000,000,000		-813,000,000	587,000,000	2,409,000,000		36,700,000	159,500,000	836,700,000		-61,100,000	-183,600,000	445,200,000
long-lived asset impairment charges					3,000,000	15,000,000	0	0	28,000,000		2,000,000						104,000,000
charges (credits) associated with last-in, first-out inventory method				-2,000,000	-2,000,000	-246,000,000	2,000,000
changes in assets and liabilities, net of acquisitions:
repayments of long-term debt		-9,000,000	-9,000,000			-8,000,000	-9,000,000	-3,000,000	-268,000,000	-862,000,000	-408,000,000	-2,000,000	-2,000,000	-2,000,000	-10,000,000	-1,634,000,000	-2,000,000	-10,000,000	-1,025,000,000	-3,000,000	-2,000,000					-1,098,000,000	-9,000,000	-3,000,000	-2,000,000	-1,742,000,000	0	-4,000,000	-541,000,000	-1,209,000,000	-386,000,000	-5,000,000	-1,000,000	-602,000,000	-498,000,000	-402,000,000	-96,000,000	-113,000,000	-7,000,000	-3,000,000	-230,000,000					-1,139,000,000
purchase of u.s. government obligations for the satisfaction and discharge of long-term debt						0	0	0	-647,000,000
cash, cash equivalents, and restricted cash classified as assets held for sale
net increase in cash, cash equivalents, and restricted cash
cash, cash equivalents, and restricted cash at beginning of year
cash, cash equivalents, and restricted cash at end of year
less: restricted cash at end of year included in prepaid expenses and other
cash and cash equivalents at end of year
supplemental cash flow information
cash paid for:
interest
income taxes, net of refunds
canadian businesses held for sale
change in cash, cash equivalents, and restricted cash classified as assets held for sale
european businesses held for sale												-55,000,000	20,000,000	238,000,000	801,000,000
payments for debt extinguishments														0	0
exercise of put right by noncontrolling shareholders of mckesson europe ag														0	0	0	-1,031,000,000
credits associated with last-in, first-out inventory method									32,000,000		5,000,000	-23,000,000	-13,000,000	56,000,000	-33,000,000	-23,000,000	-23,000,000	77,000,000	-11,000,000	-52,000,000	-52,000,000	-138,000,000	-66,000,000	-33,000,000	-15,000,000	-146,000,000	-21,000,000
goodwill and long-lived asset impairment charges														47,000,000	1,000,000
cash, cash equivalents, and restricted cash classified within assets held for sale														-325,000,000
change in cash, cash equivalents, and restricted cash classified within assets held for sale											0	0	470,000,000
equity earnings and charges from investment in change healthcare joint venture																						-394,000,000	28,000,000
income from sales of businesses and investments																					2,000,000
goodwill and other asset impairment charges																		6,000,000	132,000,000	99,000,000	5,000,000	26,000,000	101,000,000	7,000,000	5,000,000	1,408,000,000	60,000,000
(gain) income from sales of businesses and investments
share repurchases, including shares surrendered for tax withholding																		-244,000,000	-254,000,000	-248,000,000	-24,000,000	-3,000,000	-499,000,000	-751,000,000	-701,000,000	-251,000,000	-500,000,000	-581,000,000	-307,000,000	-758,000,000	-250,000,000	-401,000,000	-300,000,000	-251,000,000	-2,002,000,000	0	-58,000,000	-652,000,000	-355,000,000	-500,000,000	-105,000,000	-344,000,000	-1,000,000	-3,000,000	-102,000,000	-2,000,000	0	-1,000,000	-127,000,000	-801,000,000	-360,000,000	0	-53,000,000													-151,000,000	0	0	-147,000,000
payments for property, plant and equipment																					-72,000,000	-120,000,000	-116,000,000	-39,000,000	-87,000,000	-117,000,000	-131,000,000	-77,000,000	-101,000,000	-136,000,000	-105,000,000	-89,000,000	-75,000,000	-158,000,000	-95,000,000	-75,000,000	-76,000,000
acquisitions, net of cash, cash equivalents and restricted cash acquired																					-4,000,000	-36,000,000	-2,000,000	-49,000,000	-46,000,000	-39,000,000	-26,000,000	-14,000,000	-826,000,000
effect of exchange rate changes on cash, cash equivalents and restricted cash																					-28,000,000	-46,000,000	5,000,000	4,000,000	18,000,000	11,000,000	-43,000,000	-9,000,000	-78,000,000
net decrease in cash, cash equivalents and restricted cash																					-1,159,000,000		709,000,000	-591,000,000	-1,034,000,000		-269,000,000	-81,000,000	-473,000,000
cash, cash equivalents and restricted cash at beginning of period																					4,023,000,000		0	0	2,981,000,000		0	0	2,672,000,000
cash, cash equivalents and restricted cash at end of period																					2,864,000,000		709,000,000	-591,000,000	1,947,000,000		-269,000,000	-81,000,000	2,199,000,000
gain on healthcare technology net asset exchange
proceeds from sale of businesses and investments																										20,000,000	35,000,000
payments received on healthcare technology net asset exchange																														0	0
net increase in cash, cash equivalents and restricted cash
cash, cash equivalents and restricted cash at beginning of year
cash, cash equivalents and restricted cash at end of year
depreciation and amortization																							228,000,000	234,000,000	229,000,000		239,000,000	240,000,000	235,000,000		234,000,000	236,000,000	227,000,000		204,000,000	217,000,000	242,000,000		220,000,000	222,000,000	229,000,000		250,000,000	259,000,000	284,000,000		159,000,000	162,000,000	154,000,000		146,000,000	142,000,000	140,000,000		137,000,000	136,000,000	135,000,000		114,000,000	118,000,000	120,000,000		126,000,000	113,000,000	111,000,000		112,000,000	112,000,000	106,000,000		93,000,000	89,000,000	89,000,000		69,000,000	69,000,000	70,000,000		71,000,000	63,000,000	64,000,000
loss (income) from equity method investment in change healthcare joint venture																									-4,000,000
income from equity method investment in change healthcare																										32,000,000	50,000,000	56,000,000	56,000,000	-23,000,000	90,000,000	61,000,000	120,000,000
settlement payment
gain from sale of businesses and investments
changes in operating assets and liabilities, net of acquisitions:
goodwill and asset impairment charges																													610,000,000
charges (credits) associated with last-in-first-out inventory method																													-21,000,000					144,000,000
share-based compensation expense																														12,000,000	0			6,000,000	30,000,000			10,000,000	35,000,000			47,000,000	45,000,000			45,000,000	42,000,000			44,000,000	41,000,000	40,000,000	42,000,000	41,000,000	35,000,000	39,000,000	39,000,000	38,000,000	33,000,000	33,000,000	33,000,000	31,000,000	30,000,000	29,000,000	24,000,000	27,000,000	19,000,000	25,000,000	28,000,000	18,000,000	26,000,000
gain from sales of businesses and equity investments
deferred revenue																														-9,000,000	4,000,000	-65,000,000	-73,000,000	-29,000,000	196,000,000	-141,000,000	-113,000,000	-54,000,000	192,000,000	-132,000,000	-126,000,000	-122,000,000	232,000,000	-117,000,000	-134,000,000	-56,000,000	231,000,000	-104,000,000	-107,000,000	-74,000,000	-98,000,000	249,000,000	-102,000,000	-56,000,000	-69,000,000	241,000,000	-50,000,000	-40,000,000	260,000,000	-109,000,000	-69,000,000	-30,000,000	251,000,000	-110,000,000	-84,000,000	-143,000,000	240,000,000	-99,000,000	-53,000,000	-12,000,000	200,000,000	-53,000,000	-37,000,000	-59,000,000	228,000,000	-13,000,000	25,000,000	72,000,000	206,000,000	-28,000,000	129,000,000	-18,100,000	181,800,000	-40,000,000	-35,300,000	-1,000,000	130,100,000	-11,900,000	-36,500,000	-41,700,000	114,100,000	-14,200,000	-7,500,000
acquisitions, net of cash and cash equivalents acquired																														-914,000,000	-105,000,000	-389,000,000	-1,485,000,000	-63,000,000	-2,133,000,000	-222,000,000	-1,819,000,000	-15,000,000	-14,000,000	-5,000,000	-6,000,000	-130,000,000	-9,000,000	-17,000,000	-14,000,000
proceeds from sale of businesses and other assets
restricted cash for acquisitions																														0	0	0	1,469,000,000	-1,441,000,000	0	0	935,000,000
effect of exchange rate changes on cash and cash equivalents																														7,000,000	34,000,000	34,000,000	75,000,000	15,000,000	-107,000,000	-40,000,000	-12,000,000	71,000,000	-52,000,000	-34,000,000	60,000,000	-175,000,000	-65,000,000	-88,000,000	9,000,000	30,000,000	-4,000,000	12,000,000	-10,000,000	-14,000,000	-4,000,000				20,000,000			2,000,000	14,000,000	4,000,000	-12,000,000	2,000,000	2,000,000	15,000,000	17,000,000	-15,000,000	-35,000,000	-8,000,000	3,000,000	0	-4,000,000
net decrease in cash and cash equivalents																														53,000,000																							-1,136,000,000				-496,000,000																														-61,100,000	-183,600,000	-76,800,000
cash and cash equivalents at beginning of year
goodwill impairment and other asset impairment charges																															0
credits associated with last-in-first-out inventory method
gain from sale of businesses and equity investments																															-108,000,000
proceeds from/ (payments for) sale of businesses and equity investments																															165,000,000
cash and cash equivalents at beginning of period																															0	0	2,783,000,000		0	0	4,048,000,000		0	0	5,341,000,000		0	0	4,193,000,000		0	0	2,456,000,000		0	0	3,149,000,000		0	0	3,612,000,000		0	0	3,731,000,000		0	0	2,109,000,000		0	0	1,362,000,000		0	0	1,954,000,000		0	-3,000,000	2,142,000,000		0	0	1,800,000,000		0	0	708,000,000		0	0	522,000,000
net increase in cash and cash equivalents																																224,000,000	-444,000,000			805,000,000	611,000,000	642,000,000	-1,953,000,000	-276,000,000	294,000,000	754,000,000	783,000,000	-301,000,000	-88,000,000			55,000,000	449,000,000		-105,000,000			-1,042,000,000	248,000,000			399,000,000	163,000,000	-215,000,000	-466,000,000	303,000,000	213,000,000	571,000,000	535,000,000			-64,000,000	-175,000,000			315,000,000	249,000,000	-59,000,000	-241,000,000	257,000,000	-142,000,000	-41,000,000	-813,000,000	587,000,000	609,000,000	767,100,000	36,700,000	159,500,000	128,700,000
charges associated with last-in-first-out inventory method																																	26,000,000			-43,000,000	47,000,000	29,000,000	33,000,000	91,000,000	91,000,000	50,000,000	95,000,000	94,000,000	98,000,000	125,000,000
gain from sale of businesses																																	-1,000,000		0
proceeds from/(payments for) sale of businesses																																	3,000,000
goodwill and other impairment charges
gain from sales of businesses																																					113,000,000	0
claim and litigation charges
litigation settlement payment
proceeds from/(payment for) sale of businesses and other assets
payment received on healthcare technology net asset exchange
goodwill impairment charge																																			0
proceeds from/(payment for) sale of businesses																																			7,000,000	3,000,000	-101,000,000
impairment charges and impairment of equity investment
litigation settlement payments																																														-19,000,000	-66,000,000	0	-20,000,000	-13,000,000	-32,000,000	-165,000,000	-273,000,000	0				0				0
proceeds from sale of businesses and equity investment																																										0
non-cash item:
fair value of debt assumed on acquisitions
conversion of celesio’s convertible bonds to equity
property acquisitions																																							-94,000,000	-101,000,000	-77,000,000	-90,000,000	-95,000,000	-105,000,000	-86,000,000	-86,000,000	-57,000,000	-63,000,000	-68,000,000	-95,000,000	-65,000,000	-40,000,000	-46,000,000	-55,000,000	-44,000,000	-68,000,000	-58,000,000	-76,000,000	-50,000,000	-55,000,000	-52,000,000	-62,000,000	-44,000,000	-51,000,000	-42,000,000	-44,000,000	-71,000,000	-40,000,000	-40,000,000	-66,000,000	-46,000,000	-48,000,000	-35,000,000	-50,000,000	-25,000,000	-25,000,000	-26,000,000	-29,000,000	-55,000,000	-39,000,000	-44,000,000	-49,000,000	-36,700,000	-31,300,000	-22,900,000	-43,400,000	-25,100,000	-16,200,000	-30,300,000	-34,200,000	-25,900,000	-29,400,000	-26,500,000	-57,000,000
proceeds from sale of businesses																																							0																																			4,000,000	0
gain from the sale of businesses
proceeds from sale of business																																									84,000,000																		0																				0				0	0	12,300,000
gain on business combination																																																		0	0	0	-81,000,000
litigation charges																																														0	18,000,000			12,000,000	0			4,000,000	27,000,000
other deferred taxes																																																	98,000,000	107,000,000	248,000,000	81,000,000	170,000,000									88,000,000				244,000,000
impairment of an equity investment
proceeds from sales of business and equity investment
fair value of debt assumed on acquisition
acquisitions, less cash and cash equivalents acquired																																															0	-42,000,000	-74,000,000		-326,000,000	-143,000,000	-108,000,000
discontinued operation – gain on sale, net of tax																																																											0
impairment of capitalized software held for sale
restricted cash for litigation charges
deferred tax benefit on litigation
deferred tax benefit on litigation charges																																																					100,000,000		-1,000,000
deferred tax (benefit) expense on litigation
asset impairment charge – capitalized software held for sale																																																											0
repayments of debt																																																							-6,000,000	-1,000,000	-16,000,000
common stock repurchases, including shares surrendered for tax withholding																																																									-672,000,000				-1,016,000,000				-298,000,000
common stock issuances																																																							40,000,000				44,000,000
changes in operating assets and liabilities, net of business acquisitions:
acquisitions of businesses, less cash and cash equivalents acquired																																																										0				0	-12,000,000			-38,000,000	0	-78,000,000	-242,000,000	-18,000,000	-541,000,000	-29,000,000	-22,000,000	-1,832,000,000	-11,000,000	-4,000,000	-91,000,000	-29,000,000	1,000,000	-567,000,000	-8,000,000	-23,200,000	-38,100,000	-10,200,000	-37,400,000				-600,000
common stock share repurchases, including shares surrendered for tax withholding																																																											-1,000,000				0
changes in operating assets and liabilities, net of business acquisition:
acquisition of business, less cash and cash equivalents acquired																																																									-105,000,000
common stock transactions – other																																																									72,000,000								31,000,000
discontinued operation — gain on sale, net of tax
impairment of investments
litigation charge																																																										0
restricted cash for litigation charge																																																														0
share repurchases, retirements																																																																		0	0
fair value of acquisition debt assumed																																																										19,000,000
changes in operating assets and liabilities, net of effect of acquisitions:
deferred tax expense on litigation credit
changes in operating assets and liabilities:
common stock transactions — other																																																													144,000,000		10,000,000
discontinued operations, net of income taxes																																																																						-2,000,000	0			0	-3,000,000
litigation charge (credit)
repayment of long-term debt																																																																		-1,000,000	-1,000,000	0	-2,000,000
income tax reserve reversals																																																																		-22,000,000	0
impact of accounts receivable sales facility																																																																			-147,000,000	172,000,000	325,000,000
deferred tax
common stock transactions — issuances																																																															51,000,000
common stock share repurchases, retirements
proceeds from short-term borrowing																																																																	5,000,000				558,000,000
litigation charge (credits)
deferred taxes (benefits) on litigation charge (credits)
excess tax benefit from share-based payment arrangements
consolidated securities litigation action settlement payments
capital stock transactions:
excess tax benefits from share-based payment arrangements																																																																		16,000,000	-1,000,000	-4,000,000	-3,000,000		-28,000,000
deferred taxes (benefits) on litigation charge (credit)
total																																																																			437,000,000				429,000,000				302,000,000	335,000,000	324,000,000	449,000,000	498,000,000	260,000,000	270,000,000	347,000,000	117,500,000	168,300,000	337,800,000
restricted cash for consolidated securities litigation action																																																																						0
esop notes and guarantees																																																																			1,000,000	-1,000,000	2,000,000	2,000,000	1,000,000	0	8,000,000	0	3,000,000	5,000,000	2,000,000	0	3,000,000	6,000,000	3,000,000	0	2,900,000	1,000,000	12,500,000	100,000	3,300,000	900,000	4,900,000	0	9,000,000	800,000	3,000,000
securities litigation charge (credit)																																																																										0	0
securities litigation settlement payments																																																																										0	-19,000,000	0	-6,000,000	-16,000,000	-158,000,000	-38,000,000	-31,000,000
proceeds from sale of notes receivable																																																																														32,000,000	0			0	20,800,000	17,500,000	21,000,000	3,200,000	7,000,000			0
proceeds from issuances of debt
repayment of debt																																																																						-153,000,000	-1,000,000	0	-8,000,000	-1,020,000,000	-3,000,000	-5,000,000	-3,000,000	-1,000,000	-3,000,000	-9,000,000	-11,000,000	-250,700,000	-3,300,000	-1,400,000	-12,900,000	-6,800,000	-3,900,000	-1,400,000	-5,400,000	-1,900,000	-134,600,000	-1,500,000	-4,500,000	-177,100,000
excess tax benefits from share-based arrangements
supplemental information:
non-cash transaction:
common stock issued in conjunction with redemption of long-term debt
securities litigation credits
consolidated securities litigation action settlement
securities litigation credit
restricted cash
income taxes
effects of changes in:
securities litigation charge
securities litigation charges
notes receivable reserve
customer settlement reserve reversal
securities litigation charge, net of tax																																																																															0	0	35,000,000
capital stock transactions
income from continuing operations																																																																																154,000,000	170,000,000					214,200,000	120,200,000	156,500,000	155,600,000	181,600,000	134,300,000			125,400,000
proceeds from issuance of debt																																																																																					23,400,000		82,600,000				-252,000,000			378,400,000
international contract loss accruals
net cash from continuing operations
discontinued operations																																																																																										400,000	-100,000	-200,000	-600,000
adjustments to reconcile to net cash provided (used) by operating activities:
securities litigation charge, net of deferred tax benefit
deferred taxes on income																																																																																			-90,500,000	15,300,000	107,200,000	-69,700,000	13,200,000	87,000,000	39,000,000	107,900,000	4,800,000	8,000,000	5,900,000
net cash provided (used) by operating activities																																																																																			152,100,000
net cash used by investing activities																																																																																			-124,700,000	-58,800,000	-96,800,000
notes receivable
capital stock transactions issuances
notes receivable issuances																																																																																					-28,000,000	2,000,000	-36,800,000	29,600,000	-3,600,000	-13,300,000	-23,500,000	-8,500,000	-10,400,000	-12,400,000
net cash provided (used) by financing activities																																																																																					97,200,000
contract loss accruals
loss on sales of businesses
cash paid (received) for:
acquisitions of businesses, less cash and equivalents acquired																																																																																							-38,300,000
dividends paid on convertible preferred securities of subsidiary trust																																																																																								-2,500,000	-2,500,000	-2,500,000	-2,500,000	-2,500,000	-2,500,000	-2,500,000
adjustments to reconcile to net cash provided (used) by operating activities
adjustments to reconcile to net cash from operating activities
accounts and drafts payable																																																																																											-32,300,000	20,000,000	-5,000,000
acquisitions of businesses, less cash and short-term investments acquired																																																																																													-1,900,000	-62,400,000
net decrease in cash and equivalents																																																																																											15,800,000	10,600,000	-268,100,000
cash and equivalents at beginning of period																																																																																											0	-100,000	557,900,000
cash and equivalents at end of period																																																																																											15,800,000	10,500,000	289,800,000
1.
net cash provided (used) by continuing operations
see financial notes.
5
adjustments to reconcile to net cash used by operating activities
securities litigation costs incurred
loss on investments
restructuring and related asset impairments
total pre-tax special charges
income tax benefit
total after-tax special charges
diluted loss (credit) per share attributable to special charges
proceeds from sales of businesses
reported net income
goodwill amortization, net of tax
adjusted net income
diluted earnings per common share
adjusted diluted earnings per common share
basic earnings per common share
adjusted basic earnings per common share

We provide you with 20 years of cash flow statements for McKesson stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of McKesson stock. Explore the full financial landscape of McKesson stock with our expertly curated income statements.

The information provided in this report about McKesson stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.